Watch GH. Know when insiders buy.
One email the day a filing lands. Free.
Work order
40
WATCH · insiders 25, shorts 55
Insiders, 90 days
−$6.3M
net selling · 0 buys, 3 sells
Congress, 90 days
0 / 0
no disclosures naming it
Big money
0 / 15
none of the tracked funds disclose it
Calls on record
0
nobody we score has called it yet
MKT CAP $21.7BP/E —DIV YIELD —FCF YIELD -1.11%REV TTM $1.2B +42.7%NET INCOME −$453.4MNET DEBT $449.5M52W 54.79 – 170.92SEC XBRL · TTM TO Invalid Date
Financials
By quarter
| Period | Revenue | YoY | Gross margin | Operating income | Net income | YoY | EPS | Op. cash flow | Capex | Free cash flow | Filed |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Q2 2026 · Jun 30 | $335M | +44.3% | 65.4% | −$129.1M | −$120.1M | — | -0.90 | −$57.8M | $11.8M | −$69.5M | Jul 30 |
| Q1 2026 · Mar 31 | $301.7M | +48.3% | 65.2% | −$121.3M | −$112.1M | — | -0.85 | −$65.6M | $5.6M | −$71.2M | May 7 |
| Q4 2025 · Dec 31derived | $281.3M | +39.4% | 64.6% | −$120.8M | −$128.5M | — | -1.00 | −$26.4M | $27.8M | −$54.2M | Feb 19 |
| Q3 2025 · Sep 30 | $265.2M | +38.5% | 64.7% | −$99M | −$92.7M | — | -0.74 | −$35.4M | $10.3M | −$45.8M | Oct 29 |
| Q2 2025 · Jun 30 | $232.1M | +30.9% | 65.0% | −$106.4M | −$99.9M | — | -0.80 | −$60.3M | $5.6M | −$65.9M | Jul 30 |
| Q1 2025 · Mar 31 | $203.5M | +20.8% | 63.3% | −$111M | −$95.2M | — | -0.77 | −$62.7M | $4.5M | −$67.1M | May 7 |
| Q4 2024 · Dec 31derived | $201.8M | +30.2% | 61.6% | −$126M | −$111M | — | -0.90 | −$64.5M | $18.9M | −$83.4M | Feb 19 |
| Q3 2024 · Sep 30 | $191.5M | +33.9% | 61.1% | −$117.3M | −$107.8M | — | -0.88 | −$51.1M | $4.2M | −$55.3M | Oct 29 |
| Q2 2024 · Jun 30 | $177.2M | — | 59.1% | −$100.6M | −$102.6M | — | -0.84 | −$94M | $5.1M | −$99.1M | Jul 30 |
| Q1 2024 · Mar 31 | $168.5M | — | 61.2% | −$99.7M | −$115M | — | -0.94 | −$30.3M | $6.9M | −$37.2M | Apr 30 |
| Q4 2023 · Dec 31derived | $155.1M | — | — | −$197.5M | −$187M | — | -1.62 | −$78.7M | $4.1M | −$82.8M | Feb 19 |
| Q3 2023 · Sep 30 | $143M | — | — | −$113.5M | −$86.1M | — | -0.73 | −$77.8M | $2.4M | −$80.2M | Nov 6 |
By fiscal year
| Year | Revenue | Gross margin | Operating income | Net income | Net margin | EPS | Op. cash flow | Capex | Free cash flow | Buybacks | Dividends paid |
|---|---|---|---|---|---|---|---|---|---|---|---|
| FY2025 · to Dec 31 | $982M | 64.5% | −$437.2M | −$416.3M | -42.4% | -3.32 | −$184.8M | $48.3M | −$233.1M | $45M | — |
| FY2024 · to Dec 31 | $739M | 60.8% | −$443.6M | −$436.4M | -59.0% | -3.56 | −$239.9M | $35.1M | −$274.9M | $0 | — |
| FY2023 · to Dec 31 | $563.9M | 59.7% | −$564.7M | −$479.4M | -85.0% | -4.28 | −$325M | $20.5M | −$345.5M | $0 | — |
| FY2022 · to Dec 31 | $449.5M | — | −$544.4M | −$654.6M | -145.6% | -6.41 | −$309.5M | $77.5M | −$386.9M | — | — |
| FY2021 · to Dec 31 | $373.7M | — | −$411M | −$384.8M | -103.0% | -4.00 | −$209M | $75M | −$284.1M | — | — |
| FY2020 · to Dec 31 | $286.7M | — | −$254.9M | −$246.3M | -85.9% | -2.60 | −$103.9M | $36.2M | −$140.1M | $0 | — |
Every number comes from Guardant Health, Inc.'s own XBRL-tagged filings with the SEC, not a data vendor. Quarters marked derived are the fiscal year minus the three reported quarters, the same way every data provider computes Q4. Restated figures replace originals as later filings arrive.